Literature DB >> 23159268

Dextranomer/hyaluronic acid endoscopic injection is effective in the treatment of intermediate and high grade vesicoureteral reflux in patients with complete duplex systems.

Manuela Hunziker1, Nochiparambil Mohanan, Prem Puri.   

Abstract

PURPOSE: Endoscopic subureteral injection of dextranomer/hyaluronic acid has become an established alternative to long-term antibiotic prophylaxis or surgical treatment for vesicoureteral reflux. We evaluated the effectiveness of endoscopic injection of dextranomer/hyaluronic acid in intermediate and high grade vesicoureteral reflux in patients with complete duplex collecting systems.
MATERIALS AND METHODS: A total of 123 children underwent endoscopic correction of intermediate or high grade vesicoureteral reflux using injection of dextranomer/hyaluronic acid into complete duplex systems between 2001 and 2010. Vesicoureteral reflux was diagnosed by voiding cystourethrogram, and dimercapto-succinic acid scan was performed to evaluate the presence of renal scarring. Followup ultrasound and voiding cystourethrogram were performed 3 months after the outpatient procedure and renal ultrasound thereafter every 2 years. Mean followup was 6.7 years.
RESULTS: Complete duplex systems were unilateral in 110 patients and bilateral in 13. Reflux severity in the 136 refluxing units was grade II in 1 (0.7%), III in 52 (38.2%), IV in 61 (44.9%) and V in 22 (16.2%). Dimercapto-succinic acid scan revealed renal functional abnormalities in 63 children (51.2%). Vesicoureteral reflux resolved after the first endoscopic injection of dextranomer/hyaluronic acid in 93 ureters (68.4%), after a second injection in 35 (25.7%) and after a third injection in 8 (5.9%). Febrile urinary tract infection developed in 5 patients (4.1%) during followup. No patient required ureteral reimplantation or experienced significant complications.
CONCLUSIONS: Our results confirm the safety and efficacy of endoscopic injection of dextranomer/hyaluronic acid in eradicating intermediate and high grade vesicoureteral reflux in patients with complete duplex systems. We recommend this minimally invasive, 15-minute outpatient procedure as a viable option for treating intermediate and high grade vesicoureteral reflux in patients with complete duplex collecting systems.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23159268     DOI: 10.1016/j.juro.2012.11.048

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

Review 1.  Endoscopic injection therapy.

Authors:  Sang Woon Kim; Yong Seung Lee; Sang Won Han
Journal:  Investig Clin Urol       Date:  2017-06-02

2.  Outcome of salvage ureteral reimplantation after endoscopic treatment failure for high-grade vesicoureteral reflux compared to primary ureteral reimplantation.

Authors:  Tariq Burki; Muhammad S Howeiti; Maha K Almadhi; Fayez M Al Modhen; Hamdan Alhazmi; Santiago A Vallasciani; Abdulwahab E Alhams; Shahbaz W Mehmood; Ahmed M Al Shammari
Journal:  Urol Ann       Date:  2019-12-23

Review 3.  Management of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?

Authors:  Göran Läckgren; Christopher S Cooper; Tryggve Neveus; Andrew J Kirsch
Journal:  Front Pediatr       Date:  2021-03-31       Impact factor: 3.418

4.  Bilateral duplex collecting system with bilateral vesicoureteral reflux: a case report.

Authors:  Diataga Sylvestre Yonli; Marouene Chakroun; Selim Zaghbib; Delphine Ye; Abderrazak Bouzouita; Amine Derouiche; Mohamed Riadh Ben Slama; Haroun Ayed; Mohamed Cherif; Mohamed Chebil
Journal:  J Med Case Rep       Date:  2019-05-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.